Merck Sharp and Dohme Corp. v. Hospira, Inc.

E-Law Admin/ Oktober 26, 2017/ Arzneimittelrecht Schweiz/ 0Kommentare

Merck Sharp and Dohme Corp. v. Hospira, Inc., 17-1115

Affirming the district court’s determination that patents relating to aspects of the production of an antibiotic compound were obvious implementations of disclosures made in other patents that would constitute nothing more than the routine way a skilled artisan would apply the patent’s teachings.

Appellate Information

  • Argued
  • Submitted
  • Decided
  • Published 2017/10/26

Judges

Court

  • United States Federal Circuit

Counsel


e-Law Trainer

Share this Post

Hinterlasse einen Kommentar